BEDMINSTER, N.J.--(BUSINESS WIRE)-- Results from the CLUE study, a head-to-head comparison between Ready-to-Use Cardene ® I.V. (nicardipine) and labetalol in the emergency room, showed that ...
EKR Therapeutics has launched its single-use Cardene IV Ready-to-Use Bag (nicardipine HCl premixed injection) for the short-term treatment of hypertension when oral therapy is not feasible or ...
Please provide your email address to receive an email when new articles are posted on . Moderate to severe angiographic vasospasm was detected more often in controls than in those given implants. At ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback